Personalized Video-Based Educational Platform to Improve Stroke Knowledge: A Randomized Clinical Trial.

Autor: Favilla CG; Department of Neurology University of Pennsylvania Philadelphia PA USA., Reehal N; Department of Neurology University of Pennsylvania Philadelphia PA USA., Cummings SR; Department of Neurology University of Pennsylvania Philadelphia PA USA., Burdett R; Department of Neurology University of Pennsylvania Philadelphia PA USA., Stein LA; Department of Neurology University of Pennsylvania Philadelphia PA USA., Shakibajahromi B; Department of Neurology University of Pennsylvania Philadelphia PA USA., Yuan K; Department of Neurology University of Pennsylvania Philadelphia PA USA., Sloane KL; Department of Neurology University of Pennsylvania Philadelphia PA USA., Kasner SE; Department of Neurology University of Pennsylvania Philadelphia PA USA.
Jazyk: angličtina
Zdroj: Journal of the American Heart Association [J Am Heart Assoc] 2024 Aug 06; Vol. 13 (15), pp. e035176. Date of Electronic Publication: 2024 Jul 31.
DOI: 10.1161/JAHA.124.035176
Abstrakt: Background: Stroke knowledge is critical to treatment adherence and poststroke outcomes. Here, we aimed to quantify the impact of a personalized video-based educational platform to test the hypothesis that it improves patient satisfaction and stroke knowledge.
Methods and Results: In a single-center pilot randomized trial, all patients with stroke and caregivers received standard stroke education during the hospitalization, but half were randomized to receive access to MyStroke, a personalized educational platform that provided brief videos about their stroke, risk factors, medications, and poststroke lifestyle. Satisfaction, stroke knowledge, and quality of life were assessed 7, 30, and 90 days after discharge. A total of 120 subjects (96 patients and 24 caregivers) were randomized to standard education (n=59) or MyStroke. At 90 days post-stroke, those who received MyStroke were more likely to be satisfied with the stroke education the received (90% versus 73%, P =0.05) and more likely to correctly identify their stroke cause (67% versus 32%, P =0.003). However, MyStroke was not associated with a difference in self-reported quality of life (EuroQol Visual Analogue Scale: 80 versus 75, P =0.06) or general stroke knowledge (total Stroke Patient Education Retention: 5 versus 5, P =0.47). With respect to secondary end points, MyStroke increased risk factor awareness 7 and 30 days poststroke, but this difference was not significant at 90 days.
Conclusions: The MyStroke personalized video-based education platform improved patient and caregiver satisfaction while improving some aspects of personalized stroke knowledge without improving general stroke knowledge. A multicenter trial is needed to confirm these results, clarify generalizability, and target clinically relevant metrics such as stroke recurrence or adherence.
Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05118503.
Databáze: MEDLINE
Externí odkaz: